Affordable Access

deepdyve-link
Publisher Website

State of the Art in the Culture of the Human Microbiota: New Interests and Strategies.

Authors
  • Tidjani Alou, Maryam1
  • Naud, Sabrina1
  • Khelaifia, Saber1
  • Bonnet, Marion1
  • Lagier, Jean-Christophe1
  • Raoult, Didier2
  • 1 Aix-Marseille Université, IRD, MEPHI, AP-HM, Institut Hospitalo-Universitaire Méditerranée-Infection, Marseille, France. , (France)
  • 2 Aix-Marseille Université, IRD, MEPHI, AP-HM, Institut Hospitalo-Universitaire Méditerranée-Infection, Marseille, France [email protected] , (France)
Type
Published Article
Journal
Clinical Microbiology Reviews
Publisher
American Society for Microbiology
Publication Date
Dec 16, 2020
Volume
34
Issue
1
Identifiers
DOI: 10.1128/CMR.00129-19
PMID: 33115723
Source
Medline
Keywords
Language
English
License
Unknown

Abstract

The last 5 years have seen a turning point in the study of the gut microbiota with a rebirth of culture-dependent approaches to study the gut microbiota. High-throughput methods have been developed to study bacterial diversity with culture conditions aimed at mimicking the gut environment by using rich media such as YCFA (yeast extract, casein hydrolysate, fatty acids) and Gifu anaerobic medium in an anaerobic workstation, as well as media enriched with rumen and blood and coculture, to mimic the symbiosis of the gut microbiota. Other culture conditions target phenotypic and metabolic features of bacterial species to facilitate their isolation. Preexisting technologies such as next-generation sequencing and flow cytometry have also been utilized to develop innovative methods to isolate previously uncultured bacteria or explore viability in samples of interest. These techniques have been applied to isolate CPR (Candidate Phyla Radiation) among other, more classic approaches. Methanogenic archaeal and fungal cultures present different challenges than bacterial cultures. Efforts to improve the available systems to grow archaea have been successful through coculture systems. For fungi that are more easily isolated from the human microbiota, the challenge resides in the identification of the isolates, which has been approached by applying matrix-assisted laser desorption ionization-time of flight mass spectrometry technology to fungi. Bacteriotherapy represents a nonnegligible avenue in the future of medicine to correct dysbiosis and improve health or response to therapy. Although great strides have been achieved in the last 5 years, efforts in bacterial culture need to be sustained to continue deciphering the dark matter of metagenomics, particularly CPR, and extend these methods to archaea and fungi. Copyright © 2020 American Society for Microbiology.

Report this publication

Statistics

Seen <100 times